2m 2m 2m 2m 2m 2m 2m
VAXCYTE (PCVX)
NASDAQ
$57.73-$1.74 (-2.92%)
Price as of Sep 11, 2026 7:30 PM EDT- $8.8BMarket Cap
- 84.86%1-Year Change
- BiotechnologyIndustry
VAXCYTE (PCVX)
$57.73-$1.74 (-2.92%)
PCVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $59.47 | ||
Change | +$0.57 (+0.97%) | ||
Open | $60.07 | ||
High | $60.20 | ||
Low | $58.21 | ||
Previous Close | $58.90 | ||
Volume | 1,683,430 | ||
30-Day Average Volume | 1,026,412 | ||
1-Week Change | -2.76% | ||
1-Month Change | 0.42% | ||
1-Year Change | 84.86% | ||
3-Year Change | 13.45% | ||
5-Year Change | 127.33% | ||
Fundamentals | |||
Shares Outstanding | 148.8M | ||
Total Assets | $3.1B | ||
Market Cap | $8.8B | ||
Enterprise Value | $8.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$284.3M | ||
Free Cash Flow | -$236.8M | ||
EBIT | -$284.3M | ||
EBITDA | -$281.3M | ||
Net Working Capital | $1.3B | ||
EPS | -$1.97 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -30 | ||
PEG | -2 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue